Home / Letter From The Editor (page 115)

Letter From The Editor

Editor’s Note DCMS #57

We all are familiar with the effects of GLP-1 analogs and DPP-4 inhibitors, and we make choices for our patients based on the different benefits and risks of each type of drug. This week’s set of Homerun Slides, Incretins, Part 5 of 6, brings to light why there are actions …

Read More »

Editor’s Note

Each week we bring you information about drugs, techniques, studies and education for your patients and we often find that there are certain things we could learn more about. We had our staff do a survey of recent information requests and found that there were a lot of you who …

Read More »

Editor’s Note #55

Whenever we discuss GLP-1 and how it works, the discussion usually goes to the currently available analogs, Byetta or Victoza. We all know that DPP-4 inhibitors have an effect on GLP-1 but what is that effect, and how does it affect glucose control? This week’s Homerun Slides, Incretins, Part 3 …

Read More »

Letter from the Editor #595

Steve and I have always looked to the experts when it comes to diabetes care and sometimes the items we have for you are based on results in “ideal world” situations. However, few of our patients operate in a perfect world, and now there is a new diagnostic instrument based …

Read More »

Editor’s Note #54: What “They” Say

Last week, during a class I was leading, there was a lot of “they-saying” going on. Every time I tried to explain a food choice, physical activity or supplement suggestion, someone in the class would tell me that another person or medical professional had told them to do the opposite. …

Read More »

Letter from the Editor #594

This week we have another article about the value of diabetes education and self management training (See this week’s Item #2, Behavioral and Educational Interventions Effective for Patients with Poorly Controlled Diabetes). This makes over 30 in the past year and apparently our elected officials are taking notice. There is …

Read More »